ASAneeta Saxena

Aneeta Saxena

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aneeta Saxena has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neuropsychiatry for the Neurologist

    by Aneeta Saxena, David L. Perez

    In 2002, Joseph Boyd Martin, the Edward R. and Anne G. Lefler Professor of Neurobiology at Harvard University and Dean of Harvard Medical School, wrote a transformative article highlighting the need for a re-convergence of the fields of neurology, psychiatry, and neuroscience.[1] As he looked toward the 21st century, Prof. Martin wrote “The ‘brain problem’ is arguably the most difficult we will ever encounter. It is a challenge that will excite and test the limits of our creativity and imagination…. Leaders in academic medicine and the sciences at each of our institutions and at a national and international level must work to break down the barriers between disciplines to remove the obstacles for fuller collaboration and integration.” This issue of Seminars in Neurology on Neuropsychiatry is our contribution to breaking down the artificial walls that divide neurology and psychiatry, providing readers with an interdisciplinary framework for a range of complex brain-based disorders that promotes shared expertise across the clinical neurosciences.[2] [3] [4] Throughout the late 20th century, the field of neurology was driven by a biomedical approach, examining specific diagnoses and understanding disease pathologies through physiological biomarkers such as those obtained from electroencephalography, magnetic resonance imaging, cerebrospinal fluid, and genetics amongst other modalities. As neuroimaging techniques advance, and genetic-epigenetic research moves forward, a more sophisticated characterization of the disease processes occurs with the aid of computing power and large-scale databases. Nonetheless, a singular focus on neurobiology fails to deliver the promise of precision medicine. Our perspective is that a patient-centered approach for a range of neurological conditions can be advanced today by embracing the biopsychosocial model, one that allows underlying pathophysiology to be considered alongside relevant psychological and sociocultural considerations. As such, this issue has clinical assessment and treatment articles on the following topics: (1) the biopsychosocial formulation; (2) the neuropsychiatric approach to clinical assessments; (3) how to leverage psychotherapy principles to enhance neurologist–patient encounters; (4) harnessing social networks therapeutically; (5) cognitive behavioral therapy; (6) mindfulness-based psychotherapies; (7) neuromodulation; and (8) pharmacology. These treatments expand the therapeutic toolkit in neurology. Furthermore, we provide disorder-specific articles as examples of how to utilize a neuropsychiatry perspective for the following conditions; (9) functional neurological disorder; (10) mild traumatic brain injury; (11) epilepsy; (12) Parkinson's disease; and (13) mild cognitive impairment. As an epileptologist with a focus on functional (nonepileptic) seizures (A.S.) and a dual trained neurologist–psychiatrist and research scientist (D.L.P.), we are deeply indebted to the contributing authors for sharing their expertise and to the journal editors for providing us this platform to bring a neuropsychiatric perspective to the practice of clinical neurology. It is our steadfast hope that these articles will energize the next generation of neurologists and psychiatrists to develop shared expertise across the clinical neurosciences.[5] Article published online: 08 June 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

  • Neuropsychiatric Treatment Approaches for Functional Neurological Disorder: A How to Guide

    by Sara A. Finkelstein, Caitlin Adams, Aneeta Saxena, David L. Perez, Margaret Tuttle

    There is a growing body of knowledge regarding management of functional neurological disorder (FND). The aim of this article is to guide the clinician through FND clinical management, from delivery of the diagnosis, to creation of a biopsychosocially-informed treatment plan, to troubleshooting common issues that arise throughout longitudinal care. We review the evidence and core principles of both rehabilitative therapies (physical therapy, occupational therapy, and speech and language therapy) and psychological therapies for the treatment of FND, and discuss the benefits of engaging a multidisciplinary and interdisciplinary team. The optimal timing of specific therapeutic interventions is also discussed, emphasizing a patient-centered perspective. Resources for further reading, for both patients and clinicians, are provided throughout. Additional research is needed to further optimize the therapeutic approach to patients with FND, including the need to develop novel treatments for those that do not positively respond to currently available interventions. * Contributed equally as first authors. ** Contributed equally as senior authors. Article published online: 21 February 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA


  • Using the Biopsychosocial Model to Guide Patient-Centered Neurological Treatments

    by Aneeta Saxena, Sara Paredes-Echeverri, Rosa Michaelis, Stoyan Popkirov, David L. Perez

    The biopsychosocial model was defined by George L. Engel to propose a holistic approach to patient care. Through this model, physicians can understand patients in their context to aid the development of tailored, individualized treatment plans that consider relevant biological, psychological, and social–cultural–spiritual factors impacting health and longitudinal care. In this article, we advocate for the use of the biopsychosocial model in neurology practice across outpatient and inpatient clinical settings. To do so, we first present the history of the biopsychosocial model, and its relationships to precision medicine and deep phenotyping. Then, we bring the neurologist up-to-date information on the components of the biopsychosocial clinical formulation, including predisposing, precipitating, perpetuating, and protective factors. We conclude by detailing illustrative neurological case examples using the biopsychosocial model, emphasizing the importance of considering relevant psychological and social factors to aid the delivery of patient-centered clinical care in neurology. * Both contributed equally as first authors. Article published online: 03 February 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA


  • Evaluation and Management of First-Time Seizure in Adults

    by Myriam Abdennadher, Aneeta Saxena, Milena K. Pavlova

    First seizures are often perceived as devastating events by patients and their families due to the fear of having a life-long disease. One in 10 people experiences one or more seizures during their lifetime, while 1 in 26 people develops epilepsy. Acute symptomatic seizures are often related to a provoking factor or an acute brain insult and typically do not recur. Careful history and clinical examination should guide clinicians' management plans. Electroencephalography and brain imaging, preferably with epilepsy-specific magnetic resonance imaging, may help characterize both etiology and risk of seizure recurrence. Antiepileptic drugs should be initiated in patients with newly diagnosed epilepsy. In patients without an epilepsy diagnosis, the decision to prescribe drugs depends on individual risk factors for seizure recurrence and possible complications from seizures, which should be discussed with the patient. Counseling about driving and lifestyle modifications should be provided early, often at the first seizure encounter.


  • Social aspects of life in patients with functional seizures: Closing the gap in the biopsychosocial formulation

    by Ali A. Asadi-Pooya, Francesco Brigo, Kasia Kozlowska, David L. Perez, Chrisma Pretorius, Tyson Sawchuk, Aneeta Saxena, Benjamin Tolchin, Kette D. Valente